Viewing Study NCT05736835


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2026-01-02 @ 12:52 AM
Study NCT ID: NCT05736835
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-17
First Post: 2023-02-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
Sponsor: CyanVac LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module